Company: IXHL
Filing Date: 2025-06-13
Form Type: 8-K
Source: 0001213900-25-053995
Chunk: 0

Company: Incannex Healthcare Inc.
Filing Date: 2025-06-13
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item 3.01 Notice of Delisting or Failure to
Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

As of June 11, 2025, Incannex Healthcare
Inc. (the “ Company”) has begun the process to transfer the listing of its shares of common stock on The Nasdaq Stock Market
LLC (“ Nasdaq”) from The Nasdaq Global Market to The Nasdaq Capital Market. To effect this transfer, the Company must meet
the applicable requirements for continued listing on the Nasdaq Capital Market, submit an online transfer application, pay an application
fee and the application must be accepted by the staff of Nasdaq.

The Company’s application to transfer
its listing to The Nasdaq Capital Market is in connection with the Company’s efforts to become compliant with Nasdaq continued
listing requirements as previously discussed in our Current Reports on Form 8-K filed with the Securities Exchange Commission onJanuary 10, 2025andApril 25, 2025.

If the application for transfer to The
Nasdaq Capital Market is accepted, the Company’s common stock will continue to trade on Nasdaq under the symbol “ IXHL.”

Forward-Looking Statement